Yuho Najima
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 199 publications
Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Integration of novel anti-tumor agents and allogeneic hematopoietic stem cell transplantation
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 03, 2026
Disseminated adenovirus infection complicating acute graft-versus-host disease: potential for early diagnosis by immunohistochemistry
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: July 08, 2026
Peripheral neuropathy after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and electrophysiologic features.
Journal: Transplantation and cellular therapy
Published: June 07, 2026
Case Report: Immune-directed post-transplant maintenance with low-dose gemtuzumab ozogamicin and stepwise donor lymphocyte infusion in acute myeloid leukemia with t(1;3)(p36.3;q21).
Journal: Frontiers in immunology
Published: May 23, 2026
Diagnostic utility of small-bowel capsule endoscopy in patients with gastrointestinal symptoms after allogeneic hematopoietic cell transplantation
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Treatment outcomes of adult B-cell ALL with post-transplant relapse in the era of immunotherapeutic agents.
Journal: Transplantation and cellular therapy
Published: March 24, 2026
Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial.
Journal: Transplantation and cellular therapy
Published: March 13, 2026
Case Report: Immune-driven clonal selection underlying lineage switch from B-Precursor acute lymphoblastic leukemia to acute myeloid leukemia following inotuzumab ozogamicin.
Journal: Frontiers in immunology
Published: March 12, 2026
Last Updated: 09/26/2026